1. Home
  2. VIGL vs HURC Comparison

VIGL vs HURC Comparison

Compare VIGL & HURC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIGL
  • HURC
  • Stock Information
  • Founded
  • VIGL 2020
  • HURC 1968
  • Country
  • VIGL United States
  • HURC United States
  • Employees
  • VIGL N/A
  • HURC N/A
  • Industry
  • VIGL Biotechnology: Pharmaceutical Preparations
  • HURC Industrial Machinery/Components
  • Sector
  • VIGL Health Care
  • HURC Industrials
  • Exchange
  • VIGL Nasdaq
  • HURC Nasdaq
  • Market Cap
  • VIGL 89.3M
  • HURC 101.1M
  • IPO Year
  • VIGL 2022
  • HURC N/A
  • Fundamental
  • Price
  • VIGL $1.68
  • HURC $15.50
  • Analyst Decision
  • VIGL Strong Buy
  • HURC
  • Analyst Count
  • VIGL 5
  • HURC 0
  • Target Price
  • VIGL $16.33
  • HURC N/A
  • AVG Volume (30 Days)
  • VIGL 159.5K
  • HURC 16.9K
  • Earning Date
  • VIGL 03-13-2025
  • HURC 03-07-2025
  • Dividend Yield
  • VIGL N/A
  • HURC N/A
  • EPS Growth
  • VIGL N/A
  • HURC N/A
  • EPS
  • VIGL N/A
  • HURC N/A
  • Revenue
  • VIGL N/A
  • HURC $187,939,000.00
  • Revenue This Year
  • VIGL N/A
  • HURC N/A
  • Revenue Next Year
  • VIGL N/A
  • HURC N/A
  • P/E Ratio
  • VIGL N/A
  • HURC N/A
  • Revenue Growth
  • VIGL N/A
  • HURC N/A
  • 52 Week Low
  • VIGL $1.49
  • HURC $14.83
  • 52 Week High
  • VIGL $6.06
  • HURC $23.76
  • Technical
  • Relative Strength Index (RSI)
  • VIGL 32.05
  • HURC 32.19
  • Support Level
  • VIGL $1.74
  • HURC $15.40
  • Resistance Level
  • VIGL $1.94
  • HURC $15.72
  • Average True Range (ATR)
  • VIGL 0.16
  • HURC 0.50
  • MACD
  • VIGL -0.02
  • HURC 0.11
  • Stochastic Oscillator
  • VIGL 4.51
  • HURC 7.35

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

About HURC Hurco Companies Inc.

Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metal working industry through sales, service and distribution network. The company concentrated on designing user-friendly computer control systems that can be operated by both skilled and unskilled machine tool operators. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.

Share on Social Networks: